See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2012_Biospecifics_Technologies_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000875622, Biospecifics Technologies CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 13,086,503 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 3,178,570 |
| 4 | LiabilitiesCurrent | 1,116,239 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,231,881 |
| 9 | ResearchAndDevelopmentExpense | 972,078 |
| 10 | remainder_Expenses | -1,338,256 |
| 11 | remainder_Revenues | 11,395,726 |
| 12 | remainder_NetIncome | 71,603 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 16,265,073 |
| 1 | Liabilities | 1,116,239 |
| 2 | Expenses | 4,865,703 |
| 3 | Revenues | 11,395,726 |
| 4 | StockholdersEquity | 15,148,834 |
| 5 | NetIncome | 6,601,626 |
| 6 | ComprehensiveNetIncome | 6,601,626 |
| 7 | BaseVar | 16,857,172 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.56 |
| 9 | EconomicCapitalRatio | 4.83 |